Presentation is loading. Please wait.

Presentation is loading. Please wait.

Advances in Painful bladder syndrome

Similar presentations


Presentation on theme: "Advances in Painful bladder syndrome"— Presentation transcript:

1 Advances in Painful bladder syndrome
Stephen Mark Christchurch

2 Overview Diagnosis: Interstitial Cystitis [IC] vs Painful bladder syndrome [PBS] Syndrome association Medical management Surgical management

3 IC vs PBS Symptoms: Urgency, Frequency,Nocturia, Pelvic pain { bladder, urethral,vaginal, rectal,perineum} IC: Cystoscopic findings: pain on filling, inflammation and histologic abnormality Diagnosis: Exclusion all other pathology : UTI, OAB, Cancer, Endometriosis ICS 2002: “supra-pubic pain,related to bladder filling,frequency,nocturia,urgency,”without other pathology”

4 Cystoscopy General vs local Capacity [ 300 ml ] Pain on filling
Biopsy [ inflammation, granulation tissue, mast cells, fibrosis ] Ulcers [ not true ulcer bit fissure in mucosa due to filling ]

5 Associated complaints
Mental Health: Depression and Panic disorders are more common : J Urol 2008, Depression more difficult to treat in these patients Mental health, pain and urinary symptoms are correlated.

6 Medical management Analgesia Urinary alkaliniser, dilute urine
Cranberry With-hold irritants DMSO instillation Anticholinergics

7 Medical management Sub optimal Lack of efficacy
Prolonged time for effect Poor durability of effect Require: safe, effective, prompt relief of symptoms with durability

8 Medical management: Intravesical Resiniferatoxin
Previously effective in pilot studies Presumed action on pain C fibers Recent RCT 163 patients : No improvement in overall symptoms, pain, urgency…etc . J Urol 2005, Natural Hx PBS is characterised by remissions and exacerbations thus require placebo controlled RCT for effect.

9 Surgical management Botox A
Single arm pilot studies only. Small numbers Some evidence to suggest Botox may affect pain pathways Clinical effect mainly for paralysis of smooth and striated muscle Temporary effect

10 Surgical management Botox studies
Urology , 871: 13 patients. 69% improvement. [ months] Eur Urol patients. 85% improvement . 10 recurred within 5 months Little else…..

11 Surgical management Hydrodistension
Diagnostic and theraputic Capacity { 300 ml} May lead to prolonged symptom relief Rare complication of “total bladder necrosis” J Urol , 149

12 Surgical management Reconstruction
Total vs Partial cystectomy Urethral vs stomal emptying Indications: Pain location and relation to bladder, capability of CIC, bladder capacity reduced…..no other confounding issues Durable success in VERY select patients. 80% success approx. J Urol , 603

13 PBS Local management algorithm
Presentation: History, exam, MSU, GA cysto and biopsy. High volume vs Low volume. High vol: medical management, instillations, symptomatic management… occ hydrodilatation Low vol: all of the above , if resistant consider surgery

14 PBS Local results of surgery
6 patients: age Total cystectomy and bladder reconstruction 1 reoperation for leakage Pain resolution complete 3/4… 1 pouch pain All resumed “ normal” lifestyle

15 PBS Summary Debilitating common remitting disease Unknown aetiology
Impairs quality of life Poor treatment options Significant economic burden to patient and health system


Download ppt "Advances in Painful bladder syndrome"

Similar presentations


Ads by Google